Loading clinical trials...
Loading clinical trials...
Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Post-Transplant Immune-mediated Cytopenias
Conditions
Interventions
fostamatinib
Locations
1
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Start Date
November 7, 2025
Primary Completion Date
November 7, 2025
Completion Date
November 7, 2025
Last Updated
November 10, 2025
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions